|
HY-100005A-10mg
|
MedChemexpress LLC
|
Fumarate hydratase-IN-2 (sodium salt) [CAS 2070009-45-7]
|
|
Cancer-programmed cell death
|
|
|
HY-100005A-25mg
|
MedChemexpress LLC
|
Fumarate hydratase-IN-2 (sodium salt) [CAS 2070009-45-7]
|
|
Cancer-programmed cell death
|
|
|
HY-100005A-5mg
|
MedChemexpress LLC
|
Fumarate hydratase-IN-2 (sodium salt) [CAS 2070009-45-7]
|
|
Cancer-programmed cell death
|
|
|
HY-100005A-50mg
|
MedChemexpress LLC
|
Fumarate hydratase-IN-2 (sodium salt) [CAS 2070009-45-7]
|
|
Cancer-programmed cell death
|
|
|
HY-100006A-1mg
|
MedChemexpress LLC
|
MRT68921 (dihydrochloride) [CAS 2080306-21-2]
|
|
Cancer-Kinase/protease
|
|
|
HY-100006A-10mg
|
MedChemexpress LLC
|
MRT68921 (dihydrochloride) [CAS 2080306-21-2]
|
|
Cancer-Kinase/protease
|
|
|
HY-100006A-100mg
|
MedChemexpress LLC
|
MRT68921 (dihydrochloride) [CAS 2080306-21-2]
|
|
Cancer-Kinase/protease
|
|
|
HY-100006A-200mg
|
MedChemexpress LLC
|
MRT68921 (dihydrochloride) [CAS 2080306-21-2]
|
|
Cancer-Kinase/protease
|
|
|
HY-100006A-25mg
|
MedChemexpress LLC
|
MRT68921 (dihydrochloride) [CAS 2080306-21-2]
|
|
Cancer-Kinase/protease
|
|
|
HY-100006A-5mg
|
MedChemexpress LLC
|
MRT68921 (dihydrochloride) [CAS 2080306-21-2]
|
|
Cancer-Kinase/protease
|
|
|
HY-100006A-50mg
|
MedChemexpress LLC
|
MRT68921 (dihydrochloride) [CAS 2080306-21-2]
|
|
Cancer-Kinase/protease
|
|
|
HY-100007-100mg
|
MedChemexpress LLC
|
Vonoprazan [CAS 881681-00-1]
|
|
|
|
|
HY-100007-250mg
|
MedChemexpress LLC
|
Vonoprazan [CAS 881681-00-1]
|
|
|
|
|
HY-100008-10mg
|
MedChemexpress LLC
|
Peretinoin [CAS 81485-25-8]
|
|
Cancer-Kinase/protease
|
|
|
HY-100008-100mg
|
MedChemexpress LLC
|
Peretinoin [CAS 81485-25-8]
|
|
Cancer-Kinase/protease
|
|
|
HY-100008-5mg
|
MedChemexpress LLC
|
Peretinoin [CAS 81485-25-8]
|
|
Cancer-Kinase/protease
|
|
|
HY-100008-50mg
|
MedChemexpress LLC
|
Peretinoin [CAS 81485-25-8]
|
|
Cancer-Kinase/protease
|
|
|
HY-100009-10mg
|
MedChemexpress LLC
|
Ufenamate [CAS 67330-25-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-100009-100mg
|
MedChemexpress LLC
|
Ufenamate [CAS 67330-25-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-100009-5mg
|
MedChemexpress LLC
|
Ufenamate [CAS 67330-25-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-100009-50mg
|
MedChemexpress LLC
|
Ufenamate [CAS 67330-25-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-100013A1-10mg
|
MedChemexpress LLC
|
(1R,2R)-2-PCCA (hydrochloride) [CAS 1609563-71-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100013A1-25mg
|
MedChemexpress LLC
|
(1R,2R)-2-PCCA (hydrochloride) [CAS 1609563-71-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100013A1-5mg
|
MedChemexpress LLC
|
(1R,2R)-2-PCCA (hydrochloride) [CAS 1609563-71-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-100013A1-50mg
|
MedChemexpress LLC
|
(1R,2R)-2-PCCA (hydrochloride) [CAS 1609563-71-4]
|
|
Neuroscience-Neuromodulation
|
|
